ArticleActa pharmaceutica Sinica. B2019

Design, synthesis, and biological evaluation of novel tetrahydroprotoberberine derivatives (THPBs) as proprotein convertase subtilisin/kexin type 9 (PCSK9) modulators for the treatment of hyperlipidemia.

Chenglin Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.